Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group-Reference-Cited by-同舟云学术

Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Author:

Brown Jubilee¹,Brady William E.²,Schink Julian³,Van Le Linda⁴,Leitao Mario⁵,Yamada S. Diane⁶,de Geest Koen⁷,Gershenson David M.¹

Affiliation:

1. Department of Gynecologic Oncology and Reproductive Sciences; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Gynecologic Oncology Group Statistical and Data Center; Roswell Park Cancer Institute; Buffalo New York

3. Department of Gynecologic Oncology; Northwestern University Feinberg School of Medicine; Chicago Illinois

4. University of North Carolina School of Medicine; Chapel Hill North Carolina

5. Department of Surgery; Memorial Sloan-Kettering Cancer Center; New York New York

6. Department of Obstetrics/Gynecology; NorthShore University Health System; Lake Forest Illinois

7. Department of Gynecologic Oncology; University of Iowa Hospitals and Clinics; Iowa City Iowa

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference15 articles.

2. Clinicopathologic review of 118 granulosa and 82 theca cell tumors;Evans;Obstet Gynecol.,1980

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献